. Archives of Disease in Childhood, 45, 221. Bronchial provocation tests in asthma. Bronchial provocation tests are necessary for precise aetiological diagnosis in bronchial asthma. This is illustrated by the results in 9,364 bronchial provocation tests compared with skin tests and nasal tests.
The technique of bronchial provocation testing and its interpretation are described in detail.
In allergic asthma a precise aetiological diagnosis is a sine qua non for specific treatment, while the diagnosis of non-allergic or 'intrinsic asthma' is one of exclusion to be made only when no allergic cause can be shown. In some cases a precise allergy diagnosis may be made from history and skin test reactions, but these diagnostic aids are often unsatisfactory, leaving doubt as to whether the allergy diagnosis is correct for the asthmatic disease, relates to other organs only, or is quite irrelevant (Holt, 1967) . Allergy diagnosis may therefore be completed by applying provocative tests to the diseased organ (Aas, 1966a (Aas, , 1969 Bronsky and Ellis, 1969; Colldahl, 1952a, b, c; Fagerberg, 1960; Fuchs and Gronemeyer, 1967; Lowell and Schiller, 1947; Melon et al., 1964; Popa et al., 1969; Tuft et al., 1962) . The results of bronchial provocative tests in small groups of patients have been published by Aas (1966a) , Bronsky and Ellis (1969) , Citron (1967 ), Colldahl (1952b , McAllen (1961 ), Popa et al. (1969 , and Ryssing (1959) . Most of these represent experimental studies. It is the purpose of this paper to present our experiences in routine diagnostic work which has included 9,364 inhalation tests performned on a total of 1,035 asthmatic children over a 5-year period. Some of the data have been presented previously (Aas, 1966a, b, c; Aas et al., 1963) .
Methods
The allergen extract or control solution was nebulized by compressed air using an electric pump, and a plastic nebulizer (Pari-Optimal, Pari-Werk, Stamberg am See, Germany). The patient inhaled the nebulized fluid through a loosely fitting plastic face mask (Pari-Optimal) . Initially the bronchial provocation tests (BPT) were Received 21 August 1969. performed in an ordinary hospital room. A powerful electric fan connected to a wide tube collected the contaminated air from in front of the patient and carried it outside the building. The room air was renewed through a fresh-air intake at the opposite side of the room. However, when more than about six BPTs were performed during the day, the room air became so contaminated by the nebulized allergens that sensitive patients reacted to them soon after entering the room. There was also some risk of sensitization of medical staff, and the system had to be abandoned.
Two small neighbouring test chambers separated by glass walls and doors from a main test laboratory were then used. This enabled the staff in charge to keep the patients undergoing BPT under close observation while they themselves continued their duties in the main laboratory. Two patients with nurses or parents attending them could be tested simultaneously in each test box, provided they were tested with the same allergen.
To secure satisfactory ventilation of the test boxes without contaminating the air of neighbouring rooms, a modified air-conditioning system was used. Prewarmed (winter) and filtered air entered the main laboratory and passed through vent openings into the BPT boxes. A slight positive pressure was maintained in the main laboratory to counteract any backflow from the test boxes. A flexible tube close to the patient collected the contaminated air with the aid of an electrical fan and led it out of the building.
Infants and children unable to use a face mask could be tested by allowing the patient to play or sleep in the test box. The vents were closed and the air in the box slowly charged with the nebulized allergen.
Allergen extracts. The extracts used for intracutaneous testing* were used for BPT. A few extracts were made in the laboratory of the Allergy Unit by methods described elsewhere (Aas, 1966b) . Stock solutions were diluted with 0 9% saline containing 0 .5% phenol. The latter solution was used as a control solution in addition to the control solutions supplied commercially with the allergen extracts.
Skin tests. Scratch, prick, and intracutaneous tests were carried out by accepted methods, as described elsewhere (Aas, 1966a) . In the present paper only the results of intracutaneous tests are reported when comparing skin tests with bronchial tests. Skin tests were read and registered after 20 minutes, only urticarial wheal reactions being considered. Histamine solutions of 0.1 mg./ml. were used as positive controls for intracutaneous tests to allow for the individual skin reactivity of each patient. The reaction to the histamine test was recorded as three plus (+ + +). Test reactions were recorded against the histamine control. Reactions larger than that of the histamine control received additional plus marks, such that each new plus mark indicated a twofold increase in the wheal area. Four plus (+ +++) reactions thus indicated wheals twice the size of a three plus (++ +) histamine reaction.
Bronchial provocation test (BPT). The child was first allowed to become thoroughly acquainted with the equipment and the test was not begun until he was relaxed and confident. Small children sometimes needed up to 4 play sessions before this was achieved, but usually the test could be started after only a few minutes. The child first inhaled nebulized saline, and then control solution inhalation of allergen extract followed. To avoid bias the tests were performed without the patient, parents, or nurse knowing the type of allergen, the allergen extract vials being coded. Only one allergen was used per day.
In addition to allergens used in BPT because they were suspected as causes of the patient's disease, allergens were included which obviously should be tolerated by the particular patient according to the history (for instance pollen extract in winter asthma, house dust extract in summer asthma). This use of 'control allergens' served a double purpose. First, the specificity of positive reactions with other allergens was confirmed by the fact that a control allergen did not produce obstruction in that patient, though it was known to be active in other patients allergic to that allergen. Secondly, negative reactions to the control allergen extracts in patients reacting to other allergen extracts confirmed that these did not contain irritants producing non-specific bronchial reactions. BPTs were started with allergen concentrations of 10-4 to 10-9. Pollen and animal dander extracts were always initiated at very low concentrations. The more sensitive the patient as judged from history and skin test reactivity, the lower the initial concentration.
The patient was allowed to inhale the aerosol from approximately 1 ml. of each dilution, the concentration being progressively increased until reactions occurred, or until 1 ml. of the highest concentration used had been nebulized. Each dilution step was completed in 3-5 minutes, and the time needed for one complete BPT was approximately 20-40 minutes, allowing for auscultation, lung function tests, and refilling of nebulizer. After completion of a test, the patient was observed for another 20-40 minutes in a waiting room, after which time auscultation and lung function tests were repeated. In most patients a positive bronchial reaction was signalled by early symptoms and signs of typical asthma such as cough, characteristic expiratory dyspnoea, and wheezing. This usually occurred as an immediate reaction so typical that it left no doubt. PEF was much reduced and spirometry showed reduction of VC, and a flattened and prolonged expiratory curve with reduced FEV (Fig. 1 ). An initial 25% reduction of PEF was regularly followed by increasing bronchial obstruction if not immediately treated. In practice, the BPT was immediately stopped when PEF was clearly reduced; the patient was then observed without further provocation, bronchial obstruction being allowed to become evident by auscultation and spirometry before treatment was given. The use of the peak flow meter as a screening test for this purpose made it possible to detect reactions early when they were easily reversed by treatment.
Immediate reactions of the type described were regularly relieved within a few minutes by isoprenaline inhalation, indicating that the obstruction mainly was caused by spasm of the bronchial smooth muscle at this stage, and that histamine release probably played an important part. In some patients the positive bronchial reaction developed more slowly, becoming evident only i-6 hours after completion of the test. This type of reaction was often accompanied by auscultatory rhonchi, rales, and coarse crepitations, findings of obstructive bronchitis. It was usually less easily relieved by isoprenaline, but responded much better to adrenaline. The type of reaction could be indicative of mediator mechanisms other than those of histamine, such as SRS-A (slow reacting substance) or bradykinin (Aas, 1965 (Aas, , 1969 . Late reactions of this kind could also be due to immune mechanisms of an Arthus-like type in combination with a reagin-dependent one, as suggested for inhalant allergies to moulds (Pepys et al., 1968) . In several children a combination of these reactions occurred.
In some children lung function tests showed slight bronchial obstruction without other symptoms or signs of asthma, but the obstruction usually then became slowly more pronounced and eventually clinically evident in the course of a few hours. In young children in whom lung function tests could not be used, such slow reactions were particularly common and these children had to be examined by auscultation at regular intervals for several hours after completion of the test, while the test often had to be repeated to confirm the diagnosis. In retesting, if the top concentration of the extract was given for a prolonged period, the reaction was accelerated.
In 424 BPTs, as will be outlined. In 12 instances positive bronchial reactions were provoked, but some of these reactions were probably non-specific as regards the microorganisms in question.
The distribution of the allergic causes of asthma in 809 consecutive cases using BPT has been reported elsewhere (Aas, 1969 Patients truly allergic to the particular allergen regularly reacted to prolonged BPT with the diluted extract, whereas no reactions were elicited in the patients who on clinical grounds were thought to be tolerant to that allergen.
Subsequent to this trial, BPT was performed with 2 ml. twice diluted bacterial vaccines, sheep wool extract, feather extracts, and the particular house dust extract containing irritants, without provoking non-specific reactions.
Reactions to bacterial vaccines. To investigate the specificity of response to bacterial vaccines used in BPT in the concentrations reported by others (Hajos, 1960; Hampton, Johnson, and Galakatos, 1963; Popa et al., 1969) 8 patients were selected who suffered from isolated pollen allergy asthma; none of these had any bronchial obstruction except in the pollen season, nor did they have asthmatic or bronchitic episodes in connexion with common colds and other respiratory infections during winter. BPT was carried out with Bencard F 2 bacterial extract (Hajos, 1960) and with a stock bacterial vaccine containing approximately 1800 million bacteria per ml. . Five of the pollen-allergic subjects reacted with bronchial obstruction to the undiluted top concentrations of both extracts, showing them to contain non-specific irritants. This was confirmed by the fact that none of the 8 patients showed bronchial reactions after receiving subcutaneous injections of 0 5 ml. bacterial vaccines though they experienced both local and systemic effects including fever and headache.
BPT with bacterial extracts was performed in a total of 424 patients with a history indicating that asthma was triggered by upper respiratory infections. In these patients 2 ml. twofold diluted bacterial vaccine was used as the maximum dose. Positive reactions were elicited in 12 of the patients (2 8%). In one of these patients a positive bronchial reaction was provoked by an extract of Neisseria catarrhalis diluted 1 :100 (Aas, 1966a) , but when the same bacteria were cultivated on another medium (potato starch) and used in a repeated BPT four months later, no reaction occurred (Aas, 1963) .
In 70 consecutive cases not reacting to BPT with the mixed bacterial vaccine, despite reporting the asthma to be triggered by respiratory infections, an injection 0 5 of a 1 :10 dilution of the bacterial vaccine was given as a subcutaneous test injection. In no instances were bronchial reactions or any other allergic reactions elicited by such injections, though slight fever and local inflammation occurred in more than half the patients. Bronchial reactions to other known allergens were more easily elicited than previously within 72 hours of the bacterial vaccine injection, as shown by a lowered bronchial sensitivity threshold in a number of patients so studied.
Comparison of skin test and bronchial test reaction. The reactions to skin tests and to bronchial tests were compared in patients with a suggestive but not completely convincing history of bronchial allergy to various allergens. Intracutaneous tests and BPTs were performed with the same extract of the allergen in question. Discrepancies were common, comparing skin test reactivity and bronchial allergy in patients with house dust or mould allergy history (Aas, 1969) . Reliance on skin test reactions would have resulted in a 25-40% diagnostic error in these patients, and similar observations were made with animal danders, sheep wool, and pollen (Tables II, III, and IV). However, a 3+ skin test usually was found to be significant provided the history was also strongly suggestive, a fact that is partly concealed in the Tables shown. The largest discrepancies were found in the cases in which the history was only slightly suggestive, which was often the case for house dust, moulds, and sheep wool allergies. hours.
Bronchial provocation test in assessment of effect of treatment. BPT was used for the assessment of bronchial reactivity after treatment with an allergen extract for 2 to 4 years, in order to decide whether the hyposensitization ought to be continued or not (Pegelow et al., 1967) . BPT was also used when there was doubt as to whether clinical reactions in hyposensitized patients were due to exposure to the known allergens included in the hyposensitization programme or were caused by new or unknown allergens. The bronchial sensitivity threshold after treatment was compared to that found before treatment. Care was taken to perform the second BPT under the same conditions. Such assessment often but not always showed that the bronchial reactivity had been reduced following hyposensitization (Fig. 2) The reproducibility of the method has been studied by Colldahl (1952a) . BPT is certainly more reliable than the other diagnostic methods used in allergy; indeed there are few diseases in which the aetiological diagnosis can now be made so precisely as bronchial asthma. By means of BPT, the disease under study can be reproduced at will within a few minutes. When the allergen exposure is discontinued and symptomatic medication given, the patient is rapidly restored to normal fimction. Furthermore, this procedure may be quantitated to a certain degree (Itkin et al., 1963) , and the functional changes recorded.
The present material largely confirms the careful studies of bronchial provocation tests in adult patients performed by Colldahl (1952a, b, c) , except that a much higher incidence of bronchial allergy is found in childhood asthma than is the case for adult patients. As reported both by Colldahl (1952, a, b, c) and others (Bronsky and Ellis, 1969; Debelic and Virchow, 1968; Fagerberg, 1957; Holt, 1967; Kaude, 1960; Melon et al., 1964; Popa et al., 1969; Ripe, 1967) , it was found that skin tests were not to be trusted diagnostically even when the history of the patient was suggestive for the allergens giving positive skin reactions.
Clinical or experimental studies based on skin test diagnosis are, therefore, of restricted value. This applies, for instance, to attempts to evaluate the efficacy of hyposensitization treatment.
Bronchial allergy may be present when the skin test is negative (Fagerberg, 1960; Fastman and Glaser, 1963) , while positive skin tests are found in many normal non-allergic individuals (Curran and Goldman, 1961) . The reliability of skin tests in allergy diagnosis varies from allergen to allergen. Thus Colldahl (1952a, b, c) found BPT to be positive in 43% of patients with positive skin tests to the same allergen, varying from 72% for house dust to 20% for animal dander extracts. He found a positive BPT reaction in 16% of patients with a negative skin test but with a history suggesting a particular allergen.
These findings do not mean that the skin test is of no value, but rather that skin testing should be regarded as a screening procedure, which ought to be followed by more specific diagnostic tests such as BPT. BPT was indicated when discrepancies were found between bistory and skin test reactions, for allergies in which the history was diffuse or non-informative, and in patients with poor as well as excessive skin test reactivity.
Bronchial provocation tests are time consuming. They are mandatory, however, for clinical research concerned with diagnosis of bronchial asthma. They are superfluous when the patient's history and skin test reactions together form conclusive evidence.
By using nasal tests in asthma, the target organ (bronchi) is approached; though more reliable than the skin test (Popa and Al-George, 1969) , it is not an adequate substitute for bronchial tests.
The time should come when practical in vitro tests may be used as screening tests for allergy diagnosis in asthma. In vitro tests demonstrating specific reagins in serum will not, however, replace the provocation test, for it is the immunological state of the various organs that determines the allergic disease, and circulating reagins may play varying roles in different organs.
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